Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing.
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Omalizumab (Primary)
- Indications Allergic asthma
- Focus Adverse reactions
- Acronyms X-PAND
- Sponsors Genentech
- 07 Mar 2014 Status changed to completed as reported by ClinicalTrials.gov.
- 21 Apr 2009 Actual initiation date (Mar 2009) added as reported by ClinicalTrials.gov.
- 21 Apr 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.